Financial Performance: So-Young International Inc. reported total revenues of RMB378.7 million (US$52.9 million) for Q2 2025, a decrease from RMB407.4 million in Q2 2024, with a net loss of RMB36.0 million compared to a net income of RMB18.9 million in the same period last year.
Aesthetic Treatment Services Growth: Revenues from aesthetic treatment services surged to RMB144.4 million (US$20.2 million), marking a 426.1% increase from RMB27.4 million in Q2 2024, driven by the expansion of branded aesthetic centers.
Operational Highlights: The number of verified treatment visits exceeded 67,400, and active users reached over 100,400, showcasing significant growth in consumer engagement and service utilization.
Future Outlook: For Q3 2025, So-Young anticipates aesthetic treatment service revenues between RMB150.0 million and RMB170.0 million, reflecting an expected increase of 230.5% to 274.6% compared to the same quarter in 2024.
SY
$2.99+Infinity%1D
Analyst Views on SY
About SY
So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
